Assessment of Disease Severity in Parkinsonism with Fluorine-18-Fluorodeoxyglucose and PET

David Eidelberg; James R. Moeller; Tatsuya Ishikawa; Vijay Dhawan; Phoebe Spetsieris; Thomas Chaly; William Robeson; J. Robert Dahl; Donald Margouleff

Research ArticleHuman Studies

Assessment of Disease Severity in Parkinsonism with Fluorine-18-Fluorodeoxyglucose and PET

David Eidelberg, James R. Moeller, Tatsuya Ishikawa, Vijay Dhawan, Phoebe Spetsieris, Thomas Chaly, William Robeson, J. Robert Dahl and Donald Margouleff

Journal of Nuclear Medicine March 1995, 36 (3) 378-383;

David Eidelberg

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

James R. Moeller

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Tatsuya Ishikawa

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Vijay Dhawan

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Phoebe Spetsieris

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Thomas Chaly

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

William Robeson

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

J. Robert Dahl

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Donald Margouleff

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Article
Info & Metrics
PDF

This is a PDF-only article. The first page of the PDF of this article appears above.

PreviousNext

In this issue

Journal of Nuclear Medicine

Vol. 36, Issue 3

March 1, 1995

Table of Contents
Table of Contents (PDF)
Index by author
Advertising (PDF)
Back Matter (PDF)
Ed Board (PDF)
Front Matter (PDF)

Download PDF

Article Alerts

User Name *

Password *

Email *

Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following Assessment of Disease Severity in Parkinsonism with Fluorine-18-Fluorodeoxyglucose and PET

Message Subject (Your Name) has sent you a message from Journal of Nuclear Medicine

Message Body (Your Name) thought you would like to see the Journal of Nuclear Medicine web site.

Your Personal Message

Citation Tools

Assessment of Disease Severity in Parkinsonism with Fluorine-18-Fluorodeoxyglucose and PET

David Eidelberg, James R. Moeller, Tatsuya Ishikawa, Vijay Dhawan, Phoebe Spetsieris, Thomas Chaly, William Robeson, J. Robert Dahl, Donald Margouleff

Journal of Nuclear Medicine Mar 1995, 36 (3) 378-383;

Citation Manager Formats

BibTeX
Bookends
EasyBib
EndNote (tagged)
EndNote 8 (xml)
Medlars
Mendeley
Papers
RefWorks Tagged
Ref Manager
RIS
Zotero

Assessment of Disease Severity in Parkinsonism with Fluorine-18-Fluorodeoxyglucose and PET

David Eidelberg, James R. Moeller, Tatsuya Ishikawa, Vijay Dhawan, Phoebe Spetsieris, Thomas Chaly, William Robeson, J. Robert Dahl, Donald Margouleff

Journal of Nuclear Medicine Mar 1995, 36 (3) 378-383;

Share This Article:

Tweet Widget
Facebook Like
Google Plus One

Bookmark this article

User Name *

Password *

Remember my user name & password.

Jump to section

Article
Info & Metrics
PDF

No related articles found.

PubMed
Google Scholar

Cited By...

Functional Neuroimaging in Parkinson's Disease
Quantitative 1H Magnetic Resonance Spectroscopic Imaging Determines Therapeutic Immunization Efficacy in an Animal Model of Parkinson's Disease
Novelty seeking and harm avoidance in Parkinson's disease: effects of asymmetric dopamine deficiency
Metabolic correlates of levodopa response in Parkinson's disease
Metabolic Network Abnormalities in Early Huntington's Disease: An [18F]FDG PET Study
The metabolic topography of essential blepharospasm: A focal dystonia with general implications

Google Scholar

Main menu

User menu

Search

Assessment of Disease Severity in Parkinsonism with Fluorine-18-Fluorodeoxyglucose and PET

In this issue

Citation Manager Formats

Related Articles

Cited By...

More in this TOC Section

Similar Articles